Pharmacy World & Science

, 32:97 | Cite as

Safety of non-prescription medicines: knowledge and attitudes of Italian pharmacy customers

  • Laura CuzzolinEmail author
  • Giuseppina Benoni
Research Article


Objective A survey was designed to investigate customers attitudes and knowledge toward non-prescription medicines taken on a self-medication basis but not devoid of risks. Setting Community pharmacies in Italy. Method Forty-four pharmacies participated in the project. On the basis of an anonymous questionnaire, face-to-face interviews were made to customers buying a non-prescription medicine over a 2-month period. The questionnaire included information about socio-demographic characteristics of the interviewed subjects and 18 items designed to elicit information about the kind of medicine purchased and reason of use, general product knowledge in relation to quality and risks, attitudes toward this kind of drugs, concurrent prescription drug use and the quality of relationship with the pharmacist. Results During the study period, 613 interviews were collected. The most frequently non-prescription medicines purchased by customers were non-steroidal anti-inflammatory drugs, paracetamol and medicines for gastrointestinal problems. The most of interviewees referred to read carefully the package inserts or to ask information to pharmacists. Moreover, they reported to consider non-prescription medicines easy to manage and to be used only for minor ailments and for short periods. 55.3% of customers reported to have been taking at least a prescription drug, mostly antihypertensives or other cardiovascular medicines, in association with non-prescription medicines. In this situation, interviewees often did not inform pharmacists about chronic therapies. Conclusion Our interviews demonstrate that, in general, Italian customers have a cautious approach toward non-prescription medicines and are informed on their use. However, in case of a long-term use, interviewees underestimate risks related to possible physiological/pathological changes in their organism or to interactions with other drugs.


Customers attitudes Customers knowledge Drug safety Italy Community pharmacy Non-prescription drugs 



Special thanks to Pharmacists’ Association of Verona for the collaboration and to Dr. Anna Cordioli for her support.


No external sources of funding have been obtained for this work.

Conflicts of interest



  1. 1.
    Clark D, Layton D, Shakir SA. Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports. Br Med J. 2001;323:706–7. doi: 10.1136/bmj.323.7315.706.CrossRefGoogle Scholar
  2. 2.
    Oborne CA, Luzac ML. Over-the-counter medicine use prior to and during hospitalization. Ann Pharmacother. 2005;39:268–73. doi: 10.1345/aph.1D160.CrossRefPubMedGoogle Scholar
  3. 3.
    Amoako EP, Richardson-Campbell L, Kennedy-Malone L. Self-medication with over-the-counter drugs among elderly adults. J Gerontol Nurs. 2003;29:10–5.PubMedGoogle Scholar
  4. 4.
    Glintborg B, Andersen SE, Spang-Hanssen E, Dalhoff K. The use of over-the-counter drugs among surgical and medical patients. Eur J Clin Pharmacol. 2004;60:431–7. doi: 10.1007/s00228-004-0780-x.CrossRefPubMedGoogle Scholar
  5. 5.
    Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med. 2001;345:810–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Sinclair HK, Bond CM, Hannaford PC. Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues. Drug Saf. 2001;24:929–38. doi: 241206[pii].CrossRefPubMedGoogle Scholar
  7. 7.
    Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy: adverse drug-related events and potential adverse drug interactions in elderly patients presenting in an emergency department. Ann Emerg Med. 2001;38:666–71. doi: 10.1067/mem.2001.119456.CrossRefPubMedGoogle Scholar
  8. 8.
    Bond C, Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf. 2003;26:1065–74. doi: 26151[pii].CrossRefPubMedGoogle Scholar
  9. 9.
    Indermitte J, Reber D, Beutler M, Bruppacher R, Hersberger KE. Prevalence and patient awareness of selected potential drug interactions with self-medication. J Clin Pharm Ther. 2007;32:149–59. doi: 10.1111/j.1365-2710.2007.00809.x.CrossRefPubMedGoogle Scholar
  10. 10.
    Davies MJ, Krska J, Mackridge AJ, Khela A, Brown K, Museredza F. The general public’s attitudes towards medicinal products. Int J Pharm Pract. 2009;17(suppl 1):A23–4.Google Scholar
  11. 11.
    Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther. 2002;27:243–8.CrossRefPubMedGoogle Scholar
  12. 12.
    National Council on Patient Information and Education. Attitudes and beliefs about the use of over-the-counter medications: a dose of reality. A national survey of consumers and health professionals (online). 2002. Accessed 11 May 2004.
  13. 13.
    Kelsey JL, Evans AS, Thompson WD. Measurement: questionnaires. In: Kelsey JL, Evans AS, Thompson WD, editors. Methods in observational epidemiology. Oxford: Oxford University Press; 1996. p. 364–90. ISBN = 0-19-508377-6.Google Scholar
  14. 14.
    Terfenadine switches back to POM. Pharm J. 1997;259:316.Google Scholar
  15. 15.
    Sihvo S, Klaukka T, Martikainen J, Hemminki E. Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol. 2000;56:495–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35:1343–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Bissell P, Ward PR, Noyce PR. Mapping the contours of risk: consumer perceptions of non-prescription medicines. J Soc Adm Pharm. 2000;17:136–42.Google Scholar
  18. 18.
    Singh G. Gastro-intestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Am J Ther. 2000;7:115–21.CrossRefPubMedGoogle Scholar
  19. 19.
    Roumie CL, Griffin MR. Over-the-counter analgesics in older adults. A call for improved labelling and consumer education. Drugs Aging. 2004;21:485–98. doi: 2181[pii].CrossRefPubMedGoogle Scholar
  20. 20.
    Yoon SL, Schaffer SD. Herbal, prescribed and over-the-counter drug use in older women: prevalence of drug interactions. Geriatr Nurs. 2006;27:118–29. doi: 10.1016/j.gerinurse.2006.02.014.CrossRefPubMedGoogle Scholar
  21. 21.
    Sadowski DC. Drug interactions with antiacids. Mechanisms and clinical significance. Drug Saf. 1994;11:395–407.CrossRefPubMedGoogle Scholar
  22. 22.
    Hensrud DD, Engle DD, Scheitel SM. Underreporting the use of dietary supplements and nonprescription medications among patients undergoing a periodic health examination. Mayo Clin Proc. 1999;74:443–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.Section of Pharmacology, Department of Medicine & Public HealthUniversity of VeronaVeronaItaly

Personalised recommendations